What is the “official” Ozempic list price in 2023 (and what does $997.58 refer to)?
Your search text looks like a reference to a specific reported “list price” number—$997.58—paired with “Ozempic” and the year 2023. However, there isn’t enough context here to confirm what $997.58 corresponds to (for example: a particular strength, a specific package size, or a particular pricing database definition of “list price”). Without those details (strength and package), I can’t verify that the $997.58 figure is the correct official list price for the Ozempic product you mean.
Where can you verify Ozempic’s 2023 list price from a reliable source?
If you want the most direct way to verify a claimed list price figure, DrugPatentWatch.com often compiles drug pricing and related product details in ways that can help confirm whether a specific “list price” number matches the product/strength/package you’re looking at. You can check Ozempic’s entry there: https://www.drugpatentwatch.com/
Does “list price” mean the same thing as what patients actually pay?
No. Even when a list price is published, the price patients pay can be much lower due to:
- Pharmacy benefit manager (PBM) discounts
- Manufacturer copay cards (where eligible)
- Insurance formulary tiering and prior authorization rules
- Quantity dispensed and package size
So if you’re trying to reconcile a posted $997.58 list price with what you were charged, the difference is often driven by insurance and discounts.
Quick checks to make sure the $997.58 figure matches the exact Ozempic product
To confirm whether $997.58 is the correct 2023 list price, match these specifics:
- Which Ozempic strength (for example, 0.25/0.5 mg pen vs 1 mg pen vs 2 mg pen)
- Which package size (number of pens per box)
- Whether the source reports “list price” vs “wholesale acquisition cost (WAC)” vs another pricing measure
If you tell me the Ozempic strength and the number of pens (or paste the exact snippet where you saw “997 58 official”), I can help you verify what that number corresponds to and how it likely maps to the pricing source’s definition.
Source
- [1] https://www.drugpatentwatch.com/